1.
|
A LenzGA FranklinWG CheadleSystemic
inflammation after
traumaInjury3813361345200710.1016/j.injury.2007.10.003
|
2.
|
TM OsbornJK TracyJR DunneM PasqualeLM
NapolitanoEpidemiology of sepsis in patients with traumatic
injuryCrit Care Med3222342240200415640635
|
3.
|
D Nast-KolbM AufmkolkS RucholtzU
ObertackeC WaydhasMultiple organ failure still a major cause of
morbidity but not mortality in blunt multiple traumaJ
Trauma51835842200110.1097/00005373-200111000-0000311706328
|
4.
|
L HooverGV BochicchioLM NapolitanoSystemic
inflammatory response syndrome and nosocomial infection in traumaJ
Trauma61310317200610.1097/01.ta.0000229052.75460.c216917443
|
5.
|
D KehT BoehnkeS Weber-CartensImmunologic
and hemodynamic effects of ‘low-dose’ hydrocortisone in septic
shock: a double-blind, randomized, placebo-controlled, crossover
studyAm J Respir Crit Care Med1675125202003
|
6.
|
A RoquillyPJ MaheP SeguinHydrocortisone
therapy for patients with multiple trauma: the randomized
controlled HYPOLYTE
studyJAMA30512011209201110.1001/jama.2011.36021427372
|
7.
|
S HoenK AsehnouneS Brailly-TabardCortisol
response to corticotropin stimulation in trauma patients: influence
of hemorrhagic
shockAnesthesiology97807813200210.1097/00000542-200210000-0001012357144
|
8.
|
M ConfalonieriR UrbinoA
PotenaHydrocortisone infusion for severe community-acquired
pneumonia: a preliminary randomized studyAm J Respir Crit Care
Med171242248200510.1164/rccm.200406-808OC15557131
|
9.
|
T RhenJA CidlowskiAntiinflammatory action
of glucocorticoids - new mechanisms for old drugsN Engl J
Med35317111723200510.1056/NEJMra05054116236742
|
10.
|
S Ostrand-RosenbergP SinhaMyeloid-derived
suppressor cells: linking inflammation and cancerJ
Immunol18244994506200910.4049/jimmunol.080274019342621
|
11.
|
DI GabrilovichS NagarajMyeloid-derived
suppressor cells as regulators of the immune systemNat Rev
Immunol9162174200910.1038/nri250619197294
|
12.
|
AC OchoaAH ZeaC HernandezPC
RodriguezArginase, prostaglandins, and myeloid-derived suppressor
cells in renal cell carcinomaClin Cancer
Res13S721S726200710.1158/1078-0432.CCR-06-219717255300
|
13.
|
B ZhuY BandoS
XiaoCD11b+Ly-6C(hi) suppressive monocytes in
experimental autoimmune encephalomyelitisJ
Immunol17952285237200717911608
|
14.
|
MJ DelanoPO ScumpiaJS
WeinsteinMyD88-dependent expansion of an immature GR-1(+)CD11b(+)
population induces T cell suppression and Th2 polarization in
sepsisJ Exp Med20414631474200717548519
|
15.
|
VP MakarenkovaV BansalBM MattaLA PerezJB
OchoaCD11b+/Gr-1+ myeloid suppressor cells
cause T cell dysfunction after traumatic stressJ
Immunol176208520942006
|
16.
|
V MuneraPJ PopovicJ BrykStat 6-dependent
induction of myeloid derived suppressor cells after physical injury
regulates nitric oxide response to endotoxinAnn
Surg251120126201010.1097/SLA.0b013e3181bfda1c
|
17.
|
JA BrykPJ PopovicMS ZenatiV MuneraJP
PribisJB OchoaNature of myeloid cells expressing arginase 1 in
peripheral blood after traumaJ Trauma68843852201019996805
|
18.
|
AG CuencaMJ DelanoKM Kelly-ScumpiaA
paradoxical role for myeloid-derived suppressor cells in sepsis and
traumaMol Med17281292201110.2119/molmed.2010.0017821085745
|
19.
|
G VargaJ EhrchenA TsianakasGlucocorticoids
induce an activated, anti-inflammatory monocyte subset in mice that
resembles myeloid-derived suppressor cellsJ Leukoc
Biol84644650200810.1189/jlb.110776818611985
|
20.
|
J EhrchenL SteinmullerK
BarczykGlucocorticoids induce differentiation of a specifically
activated, anti-inflammatory subtype of human
monocytesBlood10912651274200710.1182/blood-2006-02-001115
|
21.
|
K BarczykJ EhrchenK
TenbrockGlucocorticoids promote survival of anti-inflammatory
macrophages via stimulation of adenosine receptor
A3Blood116446455201010.1182/blood-2009-10-24710620460503
|
22.
|
GP ChrousosThe
hypothalamic-pituitary-adrenal axis and immune-mediated
inflammationN Engl J
Med33213511362199510.1056/NEJM1995051833220087715646
|
23.
|
M KashiwabaraM MiyashitaT NomuraSurgical
trauma-induced adrenal insufficiency is associated with
postoperative inflammatory responsesJ Nihon Med
Sch74274283200710.1272/jnms.74.27417878697
|
24.
|
PE MarikGP ZalogaAdrenal insufficiency
during septic shockCrit Care
Med31141145200310.1097/00003246-200301000-0002212545007
|
25.
|
Y ChinenovI RogatskyGlucocorticoids and
the innate immune system: crosstalk with the toll-like receptor
signaling networkMol Cell
Endocrinol2753042200710.1016/j.mce.2007.04.01417576036
|
26.
|
U BaschantJ TuckermannThe role of the
glucocorticoid receptor in inflammation and immunityJ Steroid
Biochem Mol Biol1206975201010.1016/j.jsbmb.2010.03.05820346397
|
27.
|
X ChenT MurakamiJJ OppenheimOM
HowardDifferential response of murine
CD4+CD25+ and CD4+CD25−
T cells to dexamethasone-induced cell deathEur J
Immunol348598692004
|
28.
|
G BarreraV LandoniD Martire-GrecoModel of
polymicrobial peritonitis that induces the proinflammatory and
immunosuppressive phases of sepsisInfect
Immun7912801288201110.1128/IAI.01127-1021173307
|
29.
|
MG SchwachaBM ThobeT DanielWJ
HubbardImpact of thermal injury on wound infiltration and the
dermal inflammatory responseJ Surg
Res158112120201010.1016/j.jss.2008.07.03419394637
|
30.
|
LE SanderSD SackettU DierssenHepatic
acute-phase proteins control innate immune responses during
infection by promoting myeloid-derived suppressor cell functionJ
Exp Med20714531464201010.1084/jem.20091474
|
31.
|
B RearteA MagliocoL BalboaMifepristone
(RU486) restores humoral and T cell-mediated immune response in
endotoxin immunosuppressed miceClin Exp
Immunol162568577201010.1111/j.1365-2249.2010.04262.x20964639
|
32.
|
M IchikawaR WilliamsL WangT VoglG
SrikrishnaS100A8/A9 activate key genes and signaling pathways in
colon tumor progressionMol Cancer
Res9133148201110.1158/1541-7786.MCR-10-039421228116
|
33.
|
P ChengCA CorzoN LuettekeInhibition of
dendritic cell differentiation and accumulation of myeloid-derived
suppressor cells in cancer is regulated by S100A9 proteinJ Exp
Med20522352249200810.1084/jem.2008013218809714
|
34.
|
P SinhaC OkoroD FoellHH FreezeS
Ostrand-RosenbergG SrikrishnaProinflammatory S100 proteins regulate
the accumulation of myeloid-derived suppressor cellsJ
Immunol18146664675200810.4049/jimmunol.181.7.466618802069
|
35.
|
M FujitaG KohanbashW Fellows-MayleCOX-2
blockade suppresses gliomagenesis by inhibiting myeloid-derived
suppressor cellsCancer
Res7126642674201110.1158/0008-5472.CAN-10-305521324923
|
36.
|
E EruslanovI DaurkinJ ViewegY DaakaS
KusmartsevAberrant PGE metabolism in bladder tumor microenvironment
promotes immunosuppressive phenotype of tumor-infiltrating myeloid
cellsInt
Immunopharmacol11848855201110.1016/j.intimp.2011.01.033
|
37.
|
P SinhaVK ClementsAM FultonS
Ostrand-RosenbergProstaglandin E2 promotes tumor progression by
inducing myeloid-derived suppressor cellsCancer
Res6745074513200710.1158/0008-5472.CAN-06-417417483367
|
38.
|
L GeertsPG JorensJ WillemsM De LeyH
SlegersNatural inhibitors of neutrophil function in acute
respiratory distress syndromeCrit Care
Med2919201924200110.1097/00003246-200110000-0001211588452
|
39.
|
S Chollet-MartinB JourdainC GibertC ElbimJ
ChastreMA Gougerot-PocidaloInteractions between neutrophils and
cytokines in blood and alveolar spaces during ARDSAm J Respir Crit
Care Med154594601199610.1164/ajrccm.154.3.88105928810592
|
40.
|
T CondamineDI GabrilovichMolecular
mechanisms regulating myeloid-derived suppressor cell
differentiation and functionTrends
Immunol321925201110.1016/j.it.2010.10.00221067974
|